Table 4. SSTR2 IHC staining results—12 biopsies.
Patient ID | Diagnosis | Biopsy Source | Staining Intensity | Percent Cells Staining | IHC Score | Cells with IHC Staining | SUVmax 68Ga-DOTATATE | SUVmax 18F-FDG |
---|---|---|---|---|---|---|---|---|
153 | ADC | Resection | 2 | <5% | 0 | Inflam | 2.1 | 5.1 |
137 | ADC | Resection | 0 | 0 | 0 | None | 1.6 | 6.5 |
138 | ADC | Resection | 1 | <5% | 0 | NeoV | 0.8 | 5.2 |
204 | SCC | Biopsy | 1 | 30% | 2 | Inflam, NeoV | 2.5 | 15.3 |
120 | Benign | Biopsy | 0 | 0 | 0 | None | 0.8 | 3.4 |
70 | Benign | Biopsy | 0 | 0 | 0 | None | 1.2 | 0.8 |
129 | Benign | Biopsy | 0 | 0 | 0 | None | 1.2 | 0.8 |
101 | SCC/ADC | Resection | 2 | 20% | 2 | Inflam | 3.4 | 3.7 |
192 | ADC | Resection | 1 | <5% | 0 | Inflam | 1.0 | 2.3 |
40 | SCC | FNA Bx | 0 | 0 | 0 | none | 2.5 | 5.0 |
164 | ADC | FNA Bx | 0 | 0 | 0 | none | 2.6 | 9.7 |
100 | SCC | FNA Bx | 0 | 0 | 0 | none | 3.2 | 13.9 |
ADC, adenocarcinoma; SCC, squamous cell cancer; SCC/ADC, squamous cell cancer with adenosquamous features; Poorly diff, poorly differentiated lung cancer; Resection, tissue via surgical resection; Biopsy, core or wedge biopsy; FNA Bx, fine-needle aspiration biopsy; Inflam, inflammatory infiltration; LF, lymphoid follicles; NeoV, neovascular endothelium, pericytes.